• Latest Posts

Here’s my Chat with the CBO of Immunocore, the Only EU Biotech to have ever raised €300M in one Round

Exclusive from BIO-Europe 2015: Interview of Peter Llewellyn-Davies, CFO at Medigene, Munich-based Immunotherapy Biotech

Adaptimmune’s TCR Therapy Proves its Superiority over its Immuno-oncology Competitors

ADVERTISEMENT